• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 09/07/2019
Event Type  Injury  
Manufacturer Narrative
As the device remains implanted, an investigation on the device cannot be performed.The author was contacted and further details requested, such as lot- / serial no., implant date, patient data and possible root cause.Date of event was determined as date when literature article was published, here september 7, 2019.As patient age the mean age 72 years was determined and as gender male as mentioned in the article.Cbas¿ heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following publication was reviewed: initial clinical experience with the gore¿ viabahn¿ vbx balloon expandable stent-graft in branched and fenestrated endovascular aortic repair published by e.Beropoulis in the cardiovascular and interventional radiology.2019;42(3 supplement): page 328.The purpose of this study was to evaluate the initial clinical performance of the new gore¿ viabahn¿ vbx balloon expandable endoprosthesis in f/bevar.Between december 2017 and october 2018, fifty patients (41 male, mean age 72 years) fulfilled the inclusion criteria.The primary endpoint was reached in all of the 166 vbx implanted.122 branches (renal arteries: 74, superior mesenteric artery: 25 and celiac trunk: 21) sealed exclusively with vbx.It was stated that there was a single stent-related reintervention due to stent occlusion of a left renal artery postoperatively, which was treated successfully with aspiration thrombectomy and relining with a bare metal stent.
 
Manufacturer Narrative
Requests were emailed to the author to provide additional information like patient information, serial numbers, dates of procedure, onset date of occlusion, date of reintervention, imaging series, etc.The requests remained unanswered.The serial number remains unknown, therefore a review of the manufacturing records could not be performed.The device remains implanted in the patient, therefore a device evaluation could not be performed.With no additional information provided, gore is unable to perform further investigations of this complaint.H6 evaluation codes investigation findings 3221 was selected because no device investigation was able to be performed as no further information was able to be obtained from the authors (despite multiple attempts) and gore did not receive the device back for evaluation (still implanted in patient).In the instruction for use for the gore® viabahn® vbx balloon expandable endoprosthesis the following is stated: hazards and adverse events: procedure related: as with all procedures that utilize techniques for introducing a catheter into a vessel, complications may be expected.These complications include, but are not limited to: occlusion.Device related: complications and adverse events can occur when using any endovascular device.These complications include, but are not limited to: thrombosis or occlusion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12226083
MDR Text Key263465789
Report Number2017233-2021-02195
Device Sequence Number1
Product Code PRL
Combination Product (y/n)Y
Reporter Country CodeGM
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/27/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
Patient SexMale
-
-